Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of biological pathways involved in chemotherapy response in breast cancer.

Breast cancer research : BCR - 1 Jan 2008

Tordai Attila, Wang Jing, Andre Fabrice, Liedtke Cornelia, Yan Kai, Sotiriou Christos, Hortobagyi Gabriel N, Symmans W Fraser, Pusztai Lajos

Abstract excerpt

INTRODUCTION: Our goal was to examine the association between biological pathways and response to chemotherapy in estrogen receptor-positive (ER+) and ER-negative (ER-) breast tumors separately. METHODS: Gene set enrichment analysis including 852 predefined gene sets was applied to gene expressio...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemotherapy, Adjuvant
Share to Cyclophosphamide
Share to Doxorubicin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorouracil

Share to Ki-67 Antigen

Share to Lymphatic Metastasis

Share to Neoadjuvant Therapy

Share to Paclitaxel

Source

Open in PubMed Open full text

Identifiers

PMID: 18445275
DOI: 10.1186/bcr2088
PMCID: PMC2397539

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18445275-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of biological pathways involved in chemotherapy response in breast cancer.PMID 18445275Read ↗

Gene Pathways Associated With Prognosis and Chemotherapy Sensitivity in Molecular Subtypes of Breast CancerSemantic proximity Read ↗

Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic GradeSemantic proximity Read ↗

Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissuesSemantic proximity Read ↗

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular SubtypesSemantic proximity Read ↗

Molecular Classification of Estrogen Receptor-positive/Luminal Breast CancersSemantic proximity Read ↗

Understanding the Molecular Basis of Histologic GradeSemantic proximity Read ↗

Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast CancerSemantic proximity Read ↗

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial.Semantic proximity Read ↗

Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancerSemantic proximity Read ↗

Classical markers like ER and ki-67, but also survivin and pERK, could be involved in the pathological response to gemcitabine, adriamycin and paclitaxel (GAT) in locally advanced breast cancer patients: results from the GEICAM/2002-01 phase II study.Semantic proximity Read ↗

Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53Semantic proximity Read ↗

AR/ER Ratio Correlates with Expression of Proliferation Markers and with Distinct Subset of Breast TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.